A Single-Center, Single-Dose, Randomized, Open-Label, Four-Period, Four-Treatment Crossover Study Evaluating Pharmacokinetic Properties Of Low-Dose SoluMatrix Meloxicam In Healthy Adults.

Trial Profile

A Single-Center, Single-Dose, Randomized, Open-Label, Four-Period, Four-Treatment Crossover Study Evaluating Pharmacokinetic Properties Of Low-Dose SoluMatrix Meloxicam In Healthy Adults.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Meloxicam (Primary) ; Meloxicam
  • Indications Musculoskeletal pain
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Iroko Pharmaceuticals
  • Most Recent Events

    • 25 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top